A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial

Shock

Volumn 26, Issue 6, 2006, Pages 551-557

  Lin, Shu Min ^a   Huang, Chien Da ^a   Lin, Horng Chyuan ^a   Liu, Chien Ying ^a   Wang, Chun Hua ^a   Kuo, Han Pin ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Goal directed; Protocol; Sepsis; Shock; Survival

Indexed keywords

DOPAMINE; HYPERTENSIVE FACTOR; INFUSION FLUID; NORADRENALIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CHEMISTRY; BLOOD CULTURE; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUID RESUSCITATION; FUNGUS CULTURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SPUTUM CULTURE; STATISTICAL ANALYSIS; SURVIVAL; URINE CULTURE; URINE VOLUME; VITAL SIGN;

AGED; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN; PROSPECTIVE STUDIES; SEPSIS; SHOCK; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 33751228986     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000232271.09440.8f     Document Type: Article

References (33)

1. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123, 1995.
2. Lin SM, Frevert CW, Kajikawa O, Wurfel MM, Ballman K, Mongovin S, Wong VA, Selk A, Martin TR: Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol 31:162-170, 2004.
3. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150:644-654, 1993.
4. Dobkin ED, Lobe TE, Bhatia J, Oldham KT, Traber DL: The study of fecal-Escherichia coli peritonitis-induced septic shock in a neonatal pig model. Circ Shock 16:325-336, 1985.
5. Chung TW, O'Rear EA, Whitsett TL, Hinshaw LB, Smith MA: Survival factors in a canine septic shock model. Circ Shock 33:178-182, 1991.
6. Natanson C, Danner RL, Reilly JM, Doerfler ML, Hoffman WD, Akin GL, Hosseini JM, Banks SM, Elin RJ, MacVittie TJ, et al: Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 259:H1440-H1447, 1990.
7. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, Orr RA: Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 112:793-799, 2003.
8. Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 270:2699-2707, 1993.
9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
10. Burns SM, Earven S, Fisher C, Lewis R, Merrell P, Schubart JR, Truwit JD, Bleck TP: Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: one-year outcomes and lessons learned. Crit Care Med 31:2752-2763, 2003.
11. Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J: A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90:1052-1059, 2000.
12. Frey B, Macrae DJ: Goal-directed therapy may improve outcome in complex patients-depending on the chosen treatment end point. Intensive Care Med 31:508-509, 2005.
13. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871, 2002.
14. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483, 1992.
15. Kollef MH, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474, 1999.
16. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 341:586-592, 1999.
17. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727-734, 2003.
18. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327-1330, 2001.
19. Nseir S, Di Pompeo C, Soubrier S, Delour P, Lenci H, Roussel-Delvallez M, Onimus T, Saulnier F, Mathieu D, Durocher A: First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283-289, 2005.
20. Haupt MT, Gilbert EM, Carlson RW: Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis 131:912-916, 1985.
21. Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, Kochanek PM, Carcillo JA: Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med 28:2600-2607, 2000.
22. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001.
23. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993.
24. Eidelman LA, Putterman D, Putterman C, Sprung CL: The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275:470-473, 1996.
25. Drake TA, Cheng J, Chang A, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142:1458-1470, 1993.
26. Engelberts I, Samyo SK, Leeuwenberg JF, van der Linden CJ, Buurman WA: A role for ELAM-1 in the pathogenesis of MOF during septic shock. J Surg Res 53:136-144, 1992.
27. Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H: Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 116:91-100, 2005.
28. Asaka S, Shibayama Y, Nakata K: Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo. Liver 16:183-187, 1996.
29. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408-416, 2001.
30. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettila V: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31:1066-1071, 2005.
31. van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Jansen HM, Boersma WG: Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 24:241-249, 2005.
32. Waterer GW, Wunderink RG: The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 95:78-82, 2001.
33. Chalasani NP, Valdecanas MA, Gopal AK, McGowan JE Jr, Jurado RL: Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 108:932-936, 1995.